-
Molecular Analysis for Therapy Choice (MATCH)
This phase II trial studies how well treatment that is directed by genetic testing works in patients with solid tumors ...
Exact
Phase N/A
-
DREAMseq (Doublet, Randomized Evaluation in Advanced Melanoma Sequencing) a Phase III Trial
This randomized phase III trial studies how well initial treatment with ipilimumab and nivolumab followed by dabrafenib and trametinib works ...
Exact
Phase N/A
-
IUCRO-0042; Blood Drawing for Study of Peripheral Blood T-Lymphocytes and Other Parameters in patients with Metastatic Melanoma and Renal Cell ...
The purpose of this trial is to collect peripheral blood from patients with metastatic melanoma and renal cell cancer who ...
Exact
Phase N/A
-
A Phase II Study of Combining Talimogene Laherparepvec T-VEC (NSC-785349) and MK-3475 (Pembrolizumab) (NSC-776864) in Patients With Advanced Melanoma Who ...
The purpose of this study is to test any good and bad effects of the combination of study drugs called ...Exact
Phase N/A
-
A Phase I/II Study of MK-3475 (Pembrolizumab) in Children with advanced melanoma or a PD-L1 positive advanced relapsed or ...
The purpose of this study is to test the safety, tolerability and anti-tumor activity of the research study drug, pembrolizumab ...
Exact
Phase N/A
Showing - of studies